Protagonist Therapeutics Inc Stock Forecast
Protagonist Therapeutics Inc stock upgraded from Sell Candidate to Hold/Accumulate after Wednesday trading session.
(Updated on Apr 24, 2024)
The Protagonist Therapeutics Inc stock price fell by -4.28% on the last day (Wednesday, 24th Apr 2024) from $26.85 to $25.70. During the last trading day the stock fluctuated 7.77% from a day low at $25.62 to a day high of $27.61. The price has fallen in 7 of the last 10 days and is down by -7.82% for this period. Volume has increased on the last day by 1 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 326 thousand shares were bought and sold for approximately $8.39 million.
The stock is at the lower part of a very wide and horizontal trend in the short term, and normally this may pose a good buying opportunity, though a breakdown through the bottom trend line at $25.25 will give a strong sell signal and a trend shift may be expected. Given the current horizontal trend, you can expect Protagonist Therapeutics Inc stock with a 90% probability to be traded between $25.57 and $32.82 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
PTGX Signals & Forecast
A buy signal was issued from a pivot bottom point on Thursday, April 18, 2024, and so far it has risen 1.90%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Protagonist Therapeutics Inc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $25.95 and $28.11. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.
Support, Risk & Stop-loss for Protagonist Therapeutics Inc stock
Protagonist Therapeutics Inc finds support from accumulated volume at $25.57 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.99 between high and low, or 7.77%. For the last week, the stock has had daily average volatility of 4.56%.
Our recommended stop-loss: $24.51 (-4.63%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 4 days ago.)
Trading Expectations (PTGX) For The Upcoming Trading Day Of Thursday 25th
For the upcoming trading day on Thursday, 25th we expect Protagonist Therapeutics Inc to open at $26.31, and during the day (based on 14 day Average True Range), to move between $24.57 and $26.83, which gives a possible trading interval of +/-$1.13 (+/-4.41%) up or down from last closing price. If Protagonist Therapeutics Inc takes out the full calculated possible swing range there will be an estimated 8.82% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $25.57 (0.51%) than the resistance at $28.35 (10.31%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Earnings coming up
Protagonist Therapeutics Inc will release earnings BMO on Thursday, May 02, 2024.The consensus among the analysts for the expected earnings (EPS) is $2.51. We will update the financials statements for Protagonist Therapeutics Inc, that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 5.97% in the first trading day after earnings release.
Is Protagonist Therapeutics Inc stock A Buy?
Protagonist Therapeutics Inc holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.
Current score: -0.202 Hold/Accumulate Upgraded
Predicted Opening Price for Protagonist Therapeutics Inc of Thursday, April 25, 2024
| Fair opening price April 25, 2024 | Current price |
|---|---|
| $26.31 ( 2.37%) | $25.70 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for PTGX
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 28.30 | 10.12 % | |
| R2 | 27.54 | 7.16 % | ||
| R1 | 27.07 | 5.33 % | ||
| Current price: | 25.70 | |||
| Support | S1 | 25.55 | -0.584 % | |
| S2 | 25.08 | -2.41 % | ||
| S3 | 24.32 | -5.37 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 28.98 | 12.76 % | |
| R2 | 28.52 | 10.97 % | ||
| R1 | 28.35 | 10.31 % | ||
| Current price | 25.70 | |||
| Support | S1 | 25.57 | -0.506% | |
| S2 | 24.93 | -3.00% | ||
| S3 | 24.33 | -5.33% |
FAQ
Click here for our free guide on how to buy Protagonist Therapeutics Inc Stock.
